Survey
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Soriano Arandes, Antoni MSc, MD, Paediatrician Pediatric Infectious Diseases and Immunodeficiencies Unit Unit of International Health-Tuberculosis Drassanes-Vall Hebron Hospital Universitari Vall d'Hebron, Barcelona (Spain) Avda Drassanes, 17-21 08001 Barcelona Tel/Fax: 0034639712438 Email: [email protected]; [email protected] Date of birth: 16.12.1966 Number of COMB (College for Medical Doctors in Barcelona): 28118 GMC number: 7163551 1. Professional qualifications 1985-1991: Bachelor of Medicine and Surgery. Awarded with “B” level. Clinic Hospital of Barcelona. University of Barcelona (Spain). Post-Graduate training: 2014. ICH-GCP, Public Health Agency of Barcelona 2011. ICH-GCP, University of Oxford. 2010. MSc of Epidemiology. London School of Hygiene and Tropical Medicine. University of London (UK). 2009. Postgraduate Diploma of Epidemiology. London School of Hygiene and Tropical Medicine. University of London (UK). 2005. Master of Tropical Medicine and International Health. University of Barcelona (Spain). 2003. Neonatology competence obtained on behalf of the Academy of Medical Sciences of Catalonia and Balearic Islands. 1993-1996. Paediatrics and their specific fields. Hospital Clinic and Hospital Sant Joan de Déu. University of Barcelona (Spain). 2. Professional activity 2013-now: Paediatrician working at the Unit of International Health-Tuberculosis Drassanes-Vall Hebron (Barcelona). University Hospital Vall Hebron, Barcelona (Spain). PROSICS Barcelona. 2012-now: Data Manager of NENEXP cohort for HIV-exposed and HIV-uninfected children belonging to the Catalonian region hospitals network. 1 2012: Paediatrician working in the Unit of Tropical Medicine and International Health of Drassanes (Barcelona) and CAP la Pau of Barcelona city. ICS, Barcelona. 2011: Paediatric Clinical Research Fellow working for OVG conducting clinical vaccine trials. Prof. A.J. Pollard. University of Oxford (UK). 2007-2011: Member of the paediatric department of the University Hospital Joan XXIII of Tarragona (Spain). Skills: • Senior consultant of paediatric infectious diseases and emerging diseases. o Inpatient and outpatient clinics. • Member of the Steering Committee of Infectious Diseases of the hospital. • Responsible of the Unit of International Health. 2001-2007: Paediatrician at the Health Primary Centre of the Eixample in Barcelona (Spain). 2001. Paediatric department of the General Hospital of Vic (Barcelona). 1999-2004: Emergency paediatric ward at Dexeus University Institute of Barcelona (Spain). 1996-2000: Paediatric department of Hospital Comarcal of Alt Penedès (Barcelona-Spain). 1997. Paediatric Emergency Ward at Integrated Unity of Clinic Hospital-Saint John of God Hospital, participating in the critical intensive care unit. 1997- 1998: Paediatrician of the Health Primary Centre of the Olympic Village in Barcelona (Spain). 3. Teaching activity 2012-now: Coordinator and tutor of the paediatric module of PROSICS-IES-COMB Postgraduate Course for International Health. 2010-2012: Coordinator and professor of the Paediatric module of the Máster of Tropical Medicine (Universitat Autónoma de Barcelona). June-July 2010. Teaching the Course of Paediatric Emergency Department (Home MIR) addressed the staff of ICS performed at the Hospital of Tarragona Joan XXIII. Dates: From 28/06/2010 to 09/07/2010. October 2010. Teaching the Course of Infectious Diseases and International Health organized by the Hospital San Juan de Dios (Esplugues de Llobregat, Barcelona) on 7 and 8 October 2010. Topic: What take into account when a child travelling to the tropics? October 2010. Teaching the Course of training Trainers in Chagas disease. Barcelona, 19-22-26 October 2010. Department of Health. Generalitat of Catalonia. March 2009. Teacher in the Update Course in Pathology of Adolescence addressed to the staff of the ICS carried out in Primary Tarragona imparting 1.50 hours of teaching. Subject: Sexually Transmitted Diseases. The Canonja 28 of March of 2009. 2 December 2008. Clinical Guide for the management and treatment of the HIV infected pregnant woman, prevention of the vertical transmission and treatment of the newborn. University Hospital Joan XXIII of Tarragona (Spain). December 2007. Chagas disease. Experience in Brazil. University Hospital Joan XXIII of Tarragona (Spain). 4. Research activity 4.1. Lines of research HIV infection Chagas disease Tuberculosis Vaccines Pneumococcal infection 4.2. Post-doctoral stays as a visiting scholar in foreign universities or prestigious centres October/November 2006: Attachment at the Parasitological and Chagas department of the Hospital of Children “Ricardo Gutierrez” of Buenos Aires (Argentina). March/May 2007: Attachment at the Fundaçao de Tropical Medicina do Amazonas. Manaus. Brazil. Fellowship obtained from the Spanish Society of Tropical Medicine Society and International Health (SEMTSI). June-August 2008. Attachment at CISM (Center of Investigaçao em Saúde de Manhiça) of Moçambique. Fundació Clínic-AECI-Ministry of Saúde de Moçambique-Universidade Eduardo Mondlane. September-October 2014. Attachment at Red Cross Hospital (Cape Town, South Africa) visiting PID and pediatric pneumology wards. 4.3. Connections with national or international research teams Member and data manager of the NENEXP cohort group working in HIV infection and HIV vertical transmission and belonging to the COHERE net (European cohorts of HIV). Member of the Paediatric Cohort of Spanish AIDS Research Network (CoRISPe) Member of the TropNetEurop group collecting surveillance data about imported tropical diseases Member of ESPID (European Society of Paediatric Infectious Diseases) Member of the International Union against Tuberculosis and Lung diseases in the group of Child Lung Diseases Member of European Respiratory Society (ERS) Member of Working Group For Developing The Catalonian Screening Programme For Congenital Transmission Of Chagas Disease. Menber of the Catalan study group of invasive pneumococcal disease 2012-now investigator at “Red de Investigación Colaborativa de Enfermedades Tropicales” (RICET) de España. 2010-now investigator of “Red de Investigación del SIDA” (CoRIS) Spain. 4.4 Clinical trials 3 Health Authority File Number: EudraCT #: 2013-001231-51 WHO Universal Trial Number (UTN): U1111-1127-7504 Protocol code: GQM05 Title: Efficacy and Immunogenicity Study of Quadrivalent Influenza Vaccine Administered via the Intramuscular Route in Healthy Children Aged 6 to 35 Months. Sponsor: Sanofi-Pasteur SA. Investigational Product: Quadrivalent Influenza Vaccine (split virion, inactivated) Form / Route: Suspension for injection / Intramuscular or deep subcutaneous Indication For This Study: Prophylaxis of influenza in children aged 6 to 35 months Investigador & Centro/Hospital: Dra. Angels Jubert Rosich y Dra. María Espiau, Institut Catala de la Salut. CAP Guineueta y CAP Maragall, Barcelona (España). Número de Pacientes: 30. Fecha Inicio del Ensayo: 15-Sep-2014 Fecha Finalización del Ensayo: 31-Jul-2016 COORDINATOR IN BARCELONA. 5. Publications and articles 5.1. Chapters of medical and scientific books 2012. Chapter of book: Soriano Arandes A. and Gómez Bertomeu F. Echinococcosis/Hydatidosis. “Current Topics in Tropical Medicine” edited by Alfonso J. Rodriguez-Morales, ISBN 978-953-51-0274-8, Hard cover, 564 pages, Publisher: InTech, Published: March 16, 2012 under CC BY 3.0 license. Chapter 21 of the advanced guidelines for “Enfermedades Infecciosas de Pediatría de la Sociedad Española de Infectología Pediátrica” (SEIP): "Severe helminthiasis". 5.2. Articles in scientific journals Soriano Arandes A., Muñoz Gutierrez J., Vergés Navarro M., Castells Doménech C., Portús Vinyeta M., Gascón Brustenga J. Prevalence of Chagas disease in the Latin American immigrant population in a primary health centre in Barcelona (Spain) Acta Tropica 2009; 112: 228–230. Tipo de publicación: A. FI: 2.519. Jordi Rello, Emili Díaz, Alejandro Rodríguez, Diego de Mendoza, Thiago Lisboa, Ignacio MartínLoeches, Antonio Soriano. Protocolo de manejo de la Insuficiencia Respiratoria Aguda Grave en pacientes con Neumonía Viral Primaria por el nuevo virus de la GripeA (H1N1) en UCI. http://www.msps.es/servCiudadanos/alertas/pdf/ProtocoloGripeAenUCI.pdf Soriano Arandes A., Gómez Bertomeu F., Maldonado Artero J. Microscopic image of the protoscolex of Echinococcus granulosus on the “hydatid sand”. Am J Trop Med Hyg. 2010 Jun; 82(6):980. doi: 10.4269/ajtmh.2010.09-0743. Tipo de publicación: A. FI: 2.736. César S., García A., Parada E., Soriano A. 4 Cavernous sinus trombosis due to invasive communtiy-associated methicillin-resistant Staphylococcus aureus infection. Enferm Infecc Microbiol Clin. 2010 Dec; 28(10):755-6. doi: 10.1016/j.eimc.2009.12.012.Tipo de publicación: A. FI: 1.881. Veloso S, Peraire J, Viladés C, López-Dupla M, Escoté X, Olona M, Garcia-Pardo G, GómezBertomeu F, Soriano A, Sirvent JJ, Vidal F. Pharmacogenetics of the Metabolic Disturbances and Atherosclerosis Associated with Antiretroviral Therapy in HIV-Infected Patients. Curr Pharm Des. 2010 Oct;16(30):3379-89. Tipo de publicación: R. FI: 3.288. Yebra G, de Mulder M, Martín L, Pérez-Cachafeiro S, Rodríguez C, Labarga P, García F, Tural C, Jaén A, Navarro G, Holguín A; Cohort of Spanish AIDS Research Network (CoRIS). Sensitivity of seven HIV subtyping tools differs among subtypes/recombinants in the Spanish cohort of naïve HIV-infected patients (CoRIS). Antiviral Res. 2011 Jan; 89(1): 19-25. Tipo de publicación: A. FI: 3.434. Collaborator in: No relationship between TNF-α genetic variants and combination antiretroviral therapy-related lipodystrophy syndrome in HIV type 1-infected patients: a case-control study and a meta-analysis. Veloso S, Olona M, Peraire J, Viladés C, Pardo P, Domingo P, Asensi V, Broch M, Aguilar C, López-Dupla M, Aragonés G,Garcia-Pardo G, Sirvent JJ, Vendrell J, Richart C, Vidal F; Hiv Lipodystrophy Study Group. AIDS Res Hum Retroviruses. 2011 Feb; 27(2):143-52. Epub 2010 Sep 20. Basile L, Oliveira I, Ciruela P, Plasencia A; Working Group For Developing The Catalonian Screening Programme For Congenital Transmission Of Chagas Disease. The current screening programme for congenital transmission of Chagas disease in Catalonia,Spain. Euro Surveill. 2011 Sep 22; 16(38). pii: 19972. Tipo de publicación: A. FI: 4.659. Turon A, Jordan I, Bras C, Soriano A, Muñoz-Almagro C. Pneumococcus induced haemolytic-uraemic syndrome and cholecystitis. An Pediatr (Barc). 2011 Nov; 75(5):351-2. Tipo de publicación: A. FI: 0.722. Muñoz-Almagro C, Ciruela P, Esteva C, Marco F, Navarro M, Bartolome R, Sauca G, Gallés C, Morta M, Ballester F, Raga X, Selva L; Catalan study group of invasive pneumococcal disease. Serotypes and clones causing invasive pneumococcal disease before the use of new conjugate vaccines in Catalonia, Spain. J Infect. 2011 Aug; 63(2):151-62. Tipo de publicación: A. FI: 4.017. Pérez-Molina JA, Rodríguez-Guardado A, Soriano A, Pinazo MJ, Carrilero B, García-Rodríguez M, Salas J, Torrús D, Soler-Ferrer C, Puente S, Haro-González JL, Martín-Rabadán P, Gascon J, On Behalf Of The Chagas Study Group Of The Semtsi (Sociedad Española de Medicina Tropical Y Salud Internacional). Guidelines on the Treatment of Chronic Coinfection by Trypanosoma cruzi and HIV Outside Endemic Areas. HIV Clin Trials. 2011 Nov-Dec; 12(6):287-98. Tipo de publicación: A. FI: 2.141. Sobrino-Vegas P, Gutiérrez F, Berenguer J, Labarga P, García F, Alejos-Ferreras B, Muñoz MA, Moreno S, del Amo J; CoRIS. The Cohort of the Spanish HIV Research Network (CoRIS) and its associated biobank; organizational issues, main findings and losses to follow-up. 5 Enferm Infecc Microbiol Clin. 2011 Nov;29(9):645-53. doi: 10.1016/j.eimc.2011.06.002. Epub 2011 Aug 5. Spanish. Tipo de publicación: A. FI: 1.881. Collaborator in: Use of early corticosteroid therapy on ICU admission in patients affected by severe pandemic (H1N1)v influenza A infection. Martin-Loeches I, Lisboa T, Rhodes A, Moreno RP, Silva E, Sprung C, Chiche JD, Barahona D, Villabon M, Balasini C, Pearse RM, Matos R, Rello J; ESICM H1N1 Registry Contributors. Intensive Care Med. 2011 Feb; 37(2): 272-83. Yebra G, de Mulder M, Martín L, Rodríguez C, Labarga P, Viciana I, Berenguer J, Alemán MR, Pineda JA, García F, Holguín A; Cohort of the Spanish AIDS Research Network (CoRIS). Most HIV type 1 non-B infections in the Spanish cohort of antiretroviral treatment-naïve HIVinfected patients (CoRIS) are due to recombinant viruses. J Clin Microbiol. 2012 Feb; 50(2):407-13. doi: 10.1128/JCM.05798-11. Epub 2011 Dec 7. Tipo de publicación: A. FI: 4.232. Sobrino-Vegas P, Rodríguez-Urrego J, Berenguer J, Caro-Murillo AM, Blanco JR, Viciana P, Moreno S, Bernardino I, del Amo J; CoRIS. Educational gradient in HIV diagnosis delay, mortality, antiretroviral treatment initiation and response in a country with universal health care. Antivir Ther. 2012; 17(1):1-8. doi: 10.3851/IMP1939. Tipo de publicación: A. FI: 3.143. Hernando V, Sobrino-Vegas P, Burriel MC, Berenguer J, Navarro G, Santos I, Reparaz J, Martínez MA, Antela A, Gutiérrez F, del Amo J; CoRIS cohort. Differences in the causes of death of HIV-positive patients in a cohort study by data sources and coding algorithms. AIDS. 2012 Sep 10; 26(14):1829-34. Tipo de publicación: A. FI: 6.557. Masiá M, Pérez-Cachafeiro S, Leyes M, López-Aldeguer J, López M, Segura F, Blanco JR, Peña A, Rodríguez F, Vera M, Del Amo J, Gutiérrez F; Grupo de estudio de riesgo cardiovascular de CoRIS. Cardiovascular risk in human immunodeficiency virus-infected patients in Spain. CoRIS cohort, 2011. Enferm Infecc Microbiol Clin. 2012 Nov;30(9):517-27. doi: 10.1016/j.eimc.2012.02.014. Epub 2012 Apr 30. Spanish. Tipo de publicación: A. FI: 1.881. May MT, Hogg RS, Justice AC, Shepherd BE, Costagliola D, Ledergerber B, Thiébaut R, Gill MJ, Kirk O, van Sighem A, Saag MS, Navarro G, Sobrino-Vegas P, Lampe F, Ingle S, Guest JL, Crane HM, D'Arminio Monforte A, Vehreschild JJ, Sterne JA; Antiretroviral Therapy Cohort Collaboration (ART-CC). Heterogeneity in outcomes of treated HIV-positive patients in Europe and North America: relation with patient and cohort characteristics. Int J Epidemiol. 2012 Dec;41(6):1807-20. doi: 10.1093/ije/dys164. Epub 2012 Nov 12. Tipo de publicación: A. FI: 9.197. Monge S, Alejos B, Dronda F, Del Romero J, Iribarren JA, Pulido F, Rubio R, Miró JM, Gutierrez F, Del Amo J; CoRIS. Inequalities in HIV disease management and progression in migrants from Latin America and subSaharan Africa living in Spain. HIV Med. 2013 May; 14(5):273-83. doi: 10.1111/hiv.12001. Epub 2012 Nov 21. Erratum in: HIV Med. 2014 Jan; 15(1):64. Tipo de publicación: A. FI: 3.454. 6 Salvador F, Treviño B, Sulleiro E, Pou D, Sánchez-Montalvá A, Cabezos J, Soriano A, Serre N, Gómez I Prat J, Pahissa A, Molina I. Trypanosoma cruzi infection in a non-endemic country: epidemiological and clinical profile. Clin Microbiol Infect. 2013 Nov 7. doi: 10.1111/1469-0691.12443. Suárez-García I, Sobrino-Vegas P, Tejada A, Viciana P, Ribas M, Iribarren J, Díaz Menéndez M, Rivero M, Arazo P, Del Amo J, Moreno S; Cohort of the Spanish AIDS Research Network (CoRIS) study group. Compliance with national guidelines for HIV treatment and its association with mortality and treatment outcome: a study in a Spanish cohort. HIV Med. 2014 Feb;15(2):86-97. doi: 10.1111/hiv.12078. Epub 2013 Sep 6. Tipo de publicación: A. FI: 3.454. Soriano-Arandes A, Basile L, Ouaarab H, Clavería I, Gómez i Prat J, Cabezos J, Ciruela P, AlbajarViñas P, Jané M. Controlling congenital and paediatric chagas disease through a community health approach with active surveillance and promotion of paediatric awareness. BMC Public Health. 2014 Nov 21; 14:1201. doi: 10.1186/1471-2458-14-1201. Tipo de publicación: A. FI: 2.321. Marzolini C, Sabin C, Raffi F, Siccardi M, Mussini C, Launay O, Burger D, Roca B, Fehr J, Bonora S, Mocroft A, Obel N, Dauchy FA, Zangerle R, Gogos C, Gianotti N, Ammassari A, Torti C, Ghosn J, Chêne G, Grarup J, Battegay M; Efavirenz, Obesity Project Team on behalf of Collaboration of Observational HIV Epidemiological Research Europe (COHERE) in EuroCoord. Impact of body weight on virological and immunological responses to efavirenz-containing regimens in HIV-infected, treatment-naive adults. AIDS. 2015 Jan 14;29(2):193-200. doi: 10.1097/QAD.0000000000000530. Tipo de publicación: A. FI: 6.557. Tebruegge M, Bogyi M, Soriano-Arandes A, Kampmann B; Paediatric Tuberculosis Network European Trials Group. Shortage of purified protein derivative for tuberculosis testing. Lancet. 2014 Dec 6;384(9959):2026. doi: 10.1016/S0140-6736(14)62335-7. No abstract available. Erratum in: Lancet. 2015 Jan 10;385(9963):e4. Tipo de publicación: L. FI: 39.207. Roca Saumell C, Soriano-Arandes A, Solsona Díaz L, Gascón Brustenga J; Grupo de consenso Chagas-APS. Consensus document for the detection and management of Chagas disease in primary health care in a non-endemic areas. Aten Primaria. 2015 Feb 19. pii: S0212-6567(15)00005-0. doi: 10.1016/j.aprim.2015.01.002. [Epub ahead of print] Spanish. Tipo de publicación: A. FI: 0.894. Altet N, Dominguez J, de Souza-Galvão ML, Jiménez-Fuentes MÁ, Milà C, Solsona J, SorianoArandes A, Latorre I, Lara E, Cantos A, Ferrer MD, Orcau À, Ruiz-Manzano J, Caylà J. Predicting the Development of Tuberculosis with the Tuberculin Skin Test and QuantiFERON Testing. Ann Am Thorac Soc. 2015 Feb 20. [Epub ahead of print]. Tipo de publicación: A. Kurth F, Develoux M, Mechain M, Clerinx J, Antinori S, Gjørup IE, Gascon J, Mørch K, Nicastri E, Ramharter M, Bartoloni A, Visser L, Rolling T, Zanger P, Calleri G, Salas-Coronas J, Nielsen H, JustNübling G, Neumayr A, Hachfeld A, Schmid ML, Antonini P, Pongratz P, Kern P, Saraiva da Cunha J, Soriano-Arandes A, Schunk M, Suttorp N, Hatz C, Zoller T; Tropnet Severe Malaria Investigator Group. Intravenous artesunate reduces parasite clearance time, duration of intensive care and 7 hospital treatment in patients with severe malaria in Europe: the TropNet Severe Malaria Study. Clin Infect Dis. 2015 Jul 17. pii: civ575. Impact Factor: 8.886; 5-Yr impact factor: 9.206. 6. Research projects receiving grants or funding • • • • MITOC European project studying the neurotoxicity of treatment for preventing MTCT transmission in newborns (collaboration with the COHERE group) NENEXP. Cohort of exposed-uninfected children born from HIV-infected pregnant woman. FIPSE approved for period 2008-2011. Multicentre project to investigate invasive pneumococcal infection in children. Setting: Catalonia (Spain). Grupo de Estudio de la Enfermedad Invasiva Neumocócica en Catalunya. Member of the TropNetEurop for the surveillance of imported diseases in Europe. 7. Talks and presentations at congresses March 2014. Roundtable moderator in Chagas Workshop organized by ISGlobal, Barcelona, 6-7 March 2014. November 2013. Posters at the WSPID Congress, Cape Town (South Africa) with following issues: • EOSINOPHILIA, HYPER IGE AND PARASITES IN CHILDREN ATTENDED IN A TROPICAL MEDICINE UNIT • SCREENING PROGRAM OF CONGENITAL CHAGAS DISEASE (2010-2013): IMPLEMENTATION AND ACTIVE SURVEILLANCE. • HIV MOTHER TO CHILD TRANSMISSION COHORT STUDY FROM 2000 TO 2012 IN CATALONIA (SPAIN): THE NENEXP PROJECT. • BURDEN OF GIARDIASIS AS AN IMPORTED DISEASE IN TRAVELER CHILDREN RETURNING FROM TROPICAL GEOGRAPHIC AREAS. April 2012. Presentation at the IV Jornades Catalanas de Salud Internacional, organized by the UMTSID of Barcelona (Spain): clinical case of fever in a returned child traveller. 11-12 of April 2012. June 2011. Poster at ESPID Congress, 7-11 of June in the Hague (Netherlands), talking about an outbreak of Serratia marcescens in a third level Neonatal Intensive Care Unit. June 2011. Presentation at the IV Jornades Catalanas de Salud Internacional, organized by the UMTSID of Barcelona (Spain): Failure-to-thrive and eosinophily in a girl of Guinea Ecuatorial. 6 of June 2011. November 2010. Poster at the 59th Annual Meeting of American Society of Tropical Medicine and Hygiene. Issue: Is the Risk of Plasmodium falciparum malaria increasing in very young children who are visiting friends and relatives? Are their parents conscientious of this risk? Atlanta, 3-7 November 2010. April 2010. Poster at the 15th Annual Meeting of the Spanish Society of Emergency Paediatrics. “Impact, risk factors and radiologic pattern of influenza A in the emergency department of Paediatrics”. Sevilla, 15, 16 and April 17, 2010. March 2010. Poster at the Seventh Congress of the Spanish Society of Tropical Medicine and International Health (SEMTSI). "Diagnosis of loa-loa after mammography control”. Salamanca, 2-5 March 2010. 8 September 2009. Posters at the 6th European Congress on Tropical Medicine and International Health and 1st Mediterranean Conference on Migration and Travel Health. 6-10 September 2009. Verona (Italy): • 4.14-116. Microscopic imaging findings of a hepatic hydatid cyst in a pediatric clinical case. • 4.11-073. Is visceral leishmaniasis underreported in the endemic Mediterranean region? April 2009. II Jornades Catalanas de Salud Internacional, organized by the UMTSID of Barcelona (Spain): Visceral leishmaniasis. 2-3 of april 2009. February 2009. Speaker at the 23rd Jornada de Pediatria Ambulatòria. Paediatric department of Dexeus University Institute. “Chemoprophylaxis in paediatrics”. Barcelona, 21 February 2009. December 2008. Poster at the 57th Annual Meeting of American Society of Tropical Medicine and Hygiene. “Ventricular Dysfunction in a probable myocardial tuberculosis paediatric case”. New Orleans, 7-11 December 2008. May 2008. Poster at the 15th Reunió Anual de la Societat Catalana de Pediatria. Berga, 16-17 May 2008: Vertical transmission of the HIV in Catalonia: multi-centric prospective study of the last 8 years. NENEXP group. April 2008. Posters at the Reunión Anual de la Sociedad Española de Urgencias Pediátricas. Murcia, April 2008: Fatal evolution of a paediatric pertussis infection case. 8. Courses and seminars May 2007. Scientific Session in the Tropical Fundaçao de Medicina do Amazonas. Subject: Prevalence of Illness of Chronic Chagas in immigrant population of Barcelona. 9 of May of 2007. January 2007. Invited speaker at the III Meeting of Imported Chagas disease: vertical transmission, paediatric Chagas disease and the chronic intestinal clinical presentation. “Prevalence of the Trypanosoma cruzi infection in the paediatric population and in the immigrant women of child-bearing age coming from South and Central America”. 9. Training Courses attended March 2006. II Meeting “Chagas disease: a new challenge of Public Health”. 6 March 2006. Barcelona. May 2006. V Congress of the Spanish Tropical Medicine Society and Health the International. SEMTSI. Tenerife from the 24 to the 26 of May 2006. November 2006. Seminar of Methodology of Teaching. Barcelona. January 2007. III Meeting on the Imported Chagas disease: vertical transmission, paediatric Chagas and digestive chronicle form. Barcelona 22 of gener of the 2007. March 2007. V Meeting of the Spanish Tropical Medicine Society and Health the International. “Emergent virus”. Oviedo 9-10 March 2007. May 2007. Course of Medical Entomology. Fundaçao de Tropical Medicina do Amazon. Manaus (Brazil). May 2007. 1st Symposium of Immunopathogenesis in Doenças Tropicais and Infecciosas. Fundaçao de Tropical Medicina do Amazon. Manaus (Brazil). September 2007. Centenary of the Royal Society of Tropical Medicine and Hygiene in London (UK). 9 New December 2008. 57th Annual Meeting of American Society of Tropical Medicine and Hygiene. Orleans, 7 to the 11 December of the 2008. February 2009. V Meeting of “Imported Chagas disease: Vectorial transmission and neurological complications” 09R04161. Barcelona 2 of febrer 2009. February 2010. VI Workshop "Imported Chagas Disease: Transplant immunosuppression and"Barcelona, February 1, 2010. Accredited by the Catalan Council for Continuing Medical Education of the National Health System with 0.6 credits. March 2010. VII Congress of the Spanish Society of Tropical Medicine and International Health. Salamanca, 2-5 March 2010. April 2010. XIV Update Course on Vaccines 2010. 09/00834-MD record. Barcelona, April 2010. Hospital Vall d'Hebron. Accredited by the Catalan Council for Continuing Medical Education of the National Health System with 1.8 credits. June 2010. Infection and Immunity in Children. Oxford (UK), 28-30 June 2010 at Keble College. 3 day course in Paediatric Infectious Diseases, awarded with 19.5 CPD points by the Royal College of Paediatrics and Child Health. July 2011. Infection and Immunity in Children. Oxford (UK), 14-16 July 2011 at St. Catherine’s College. 3 day course in Paediatric Infectious Diseases, awarded with 19.5 CPD points by the Royal College of Paediatrics and Child Health. August 2011. ICH-GCP, University of Oxford. 10. Fellowships, grants and prizes awarded 2006. Fellowship of the Spanish Society of Tropical Medicine and International Health (SEMTSI) for an attachment of 2 months at the Fundaçao de Medicina Tropical do Amazonas de Manaus (Brasil). 11. Languages. English, Portuguese, Spanish and Catalan languages. 12. Others: International Driver Licence. 1